Literature DB >> 20544717

Overexpression of Pim-1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma.

Hong-Tao Liu1, Ning Wang, Xin Wang, Sheng-Lei Li.   

Abstract

BACKGROUND AND OBJECTIVES: It is well known that provirus integration site for Moloney murine leukemia virus 1 (Pim-1) plays an essential role in the occurrence and development of tumors. Here, we investigated expression of Pim-1 in esophageal squamous cell carcinoma (ESCC) and assessed the correlation between Pim-1 level and prognosis of the patients with ESCC.
METHODS: Expression of Pim-1 was investigated by RT-PCR, immunohistochemistry, and in situ hybridization methods. Kaplan-Meier statistics was used to examine the relationship between levels of Pim-1 and prognosis using log-rank test.
RESULTS: The results demonstrated that ESCC tissues appeared strong expression levels of Pim-1 mRNA and protein while the normal esophageal tissues were either negative or showed only weak Pim-1 mRNA and protein levels. In addition, we found that Pim-1 expression was significantly correlated with histology grade, clinical staging, and lymph node metastasis (all P < 0.05), but not related to age and sex (all P > 0.05). Furthermore, the results of survival rates analyzed by Kaplan-Meier curve revealed that patients with high Pim-1 mRNA and protein expressions had a poorer prognosis than those with the low Pim-1 expression (P = 0.010 and 0.001, respectively).
CONCLUSION: These findings demonstrate that Pim-1 may be used as molecular marker for predicting the prognosis of patients with ESCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544717     DOI: 10.1002/jso.21627

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  25 in total

1.  Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival.

Authors:  Susann Herzog; Matthias Alexander Fink; Kerstin Weitmann; Claudius Friedel; Stefan Hadlich; Sönke Langner; Katharina Kindermann; Tobias Holm; Andreas Böhm; Eskil Eskilsson; Hrvoje Miletic; Markus Hildner; Michael Fritsch; Silke Vogelgesang; Christoph Havemann; Christoph Alexander Ritter; Henriette Elisabeth Meyer zu Schwabedissen; Bernhard Rauch; Wolfgang Hoffmann; Heyo Klaus Kroemer; Henry Schroeder; Sandra Bien-Möller
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

2.  Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents.

Authors:  Andrea L Casillas; Rachel K Toth; Alva G Sainz; Neha Singh; Ankit A Desai; Andrew S Kraft; Noel A Warfel
Journal:  Clin Cancer Res       Date:  2017-10-30       Impact factor: 12.531

3.  Alpinumisoflavone induces apoptosis in esophageal squamous cell carcinoma by modulating miR-370/PIM1 signaling.

Authors:  Yantao Han; Xiuwei Yang; Ning Zhao; Jianjun Peng; Hui Gao; Xia Qiu
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

4.  RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway.

Authors:  Hui Zhao; Jianping Yang; Tianli Fan; Shenglei Li; Xuequn Ren
Journal:  Tumour Biol       Date:  2012-04-03

5.  Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase.

Authors:  Jin H Song; Neha Singh; Libia A Luevano; Sathish K R Padi; Koichi Okumura; Virginie Olive; Stephen M Black; Noel A Warfel; David W Goodrich; Andrew S Kraft
Journal:  Mol Cancer Ther       Date:  2018-09-06       Impact factor: 6.261

6.  High expression of astrocyte elevated gene-1 is associated with clinical staging, metastasis, and unfavorable prognosis in gastric carcinoma.

Authors:  Liangpeng Dong; Shuang Qin; Yan Li; Lunde Zhao; Shuping Dong; Ying Wang; Caifeng Zhang; Shilin Han
Journal:  Tumour Biol       Date:  2014-11-19

Review 7.  PIM kinase (and Akt) biology and signaling in tumors.

Authors:  Noel A Warfel; Andrew S Kraft
Journal:  Pharmacol Ther       Date:  2015-03-05       Impact factor: 12.310

8.  WWP1 as a potential tumor oncogene regulates PTEN-Akt signaling pathway in human gastric carcinoma.

Authors:  Li Zhang; Zongyin Wu; Zhao Ma; Hongtao Liu; Yahong Wu; Qinxian Zhang
Journal:  Tumour Biol       Date:  2014-10-09

9.  PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species.

Authors:  Noel A Warfel; Alva G Sainz; Jin H Song; Andrew S Kraft
Journal:  Mol Cancer Ther       Date:  2016-05-16       Impact factor: 6.261

10.  Target protein for Xklp2 (TPX2), a microtubule-related protein, contributes to malignant phenotype in bladder carcinoma.

Authors:  Liang Yan; Shenglei Li; Changbao Xu; Xinghua Zhao; Bin Hao; Huixiang Li; Baoping Qiao
Journal:  Tumour Biol       Date:  2013-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.